Real World CCH Study in Adult Females With Cellulite
Status:
Completed
Trial end date:
2021-01-08
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, multiple dose, 2 cohort, Phase 3b study to assess the
safety and efficacy of CCH in adult women with mild or moderate edematous fibrosclerotic
panniculopathy (EFP).
Cohort 1 will include approximately 80 subjects with mild or moderate EFP in the
posterolateral thighs and Cohort 2 will include approximately 70 subjects with mild or
moderate EFP in the buttocks.